Georgina Long, Translational Research and Medical Oncology at the University of Sydney, shared a post on X by Melanoma Institute Australia, adding:
“So great to see the Melanoma Institute Australia team from around the world delivering important research results changing melanoma and cancer.”
Quoting Melanoma Institute Australia’s post:
“An update from the 22nd European Association of Dermato-Oncology (EADO) Congress being held in Prague, Czech Republic – the world’s largest conference in dermato-oncology (skin cancers).
There was standing room only when Prof Georgina Long presented the opening keynote lecture on vaccines for skin cancer, particularly melanoma. Assoc Professor Inês Pires da Silva presented during a symposium session on how the melanoma metastases location impacts effectiveness of immunotherapy.
Recent MIA fellows, now at other world leading institutions, presented work they have done whilst at MIA. Dr Francis Proulx-Rocray presented on the Australian experience of neoadjuvant immunotherapy. Dr Julia Ressler presented posters on two recent studies – genomic profiling to predict immunotherapy response in merkel cell carcinoma, and immune related hepatitis.”
Other articles about Melanoma on OncoDaily.
